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http://dx.doi.org/1disease characterized by ﬁbrofatty replacement of the myocardium and ventricular
arrhythmias, associated with mutations in the desmosomal genes. Only a missense mutation
in the DES gene coding for desmin, the intermediate ﬁlament protein expressed by cardiac
and skeletal muscle cells, has been recently associated with ARVC. We screened 91 ARVC
index cases (53 negative for mutations in desmosomal genes and an additional 38 carrying
desmosomal gene mutations) for DES mutations. Two rare missense variants were iden-
tiﬁed. The heterozygous p.K241E substitution was detected in 1 patient affected with
a severe form of ARVC who also carried the p.T816RfsX10 mutation in plakophilin-2 gene.
This DES substitution, showing an allele frequency of <0.01 in the control population, is
predicted to cause an intolerant amino acid change in a highly conserved protein domain.
Thus, it can be considered a rare variant with a possible modiﬁer effect on the phenotypic
expression of the concomitant mutation. The previously known p.A213V substitution was
identiﬁed in 1 patient with ARVC who was negative for mutations in the desmosomal
genes. Because a greater prevalence of p.A213V has been reported in patients with heart
dilation than in control subjects, the hypothesis that this rare variant could have an
unfavorable effect on cardiac remodeling cannot be ruled out. In conclusion, our data help
to establish that, in the absence of skeletal muscle involvement suggestive of a desminop-
athy, the probability of DESmutations in ARVC is very low. These ﬁndings have important
implications in the mutation screening strategy for patients with ARVC.2013Elsevier Inc.Open access under CC BY-N (Am JCardiol 2013;111:400e405)C-ND license. Arrhythmogenic right ventricular cardiomyopathy (ARVC;
MIM 107970) is an inherited cardiac disease charac-
terized by progressive ﬁbrofatty myocardial replacement,
primarily of the right ventricle.1e3 Clinical manifestations
occur most often between the second and fourth decade of life
and are characterized by ventricular arrhythmias, heart failure,
and sudden death.1,2 ARVC is the secondmost common cause
of unexpected sudden death among young people and athletes4
and affectsmenmore frequently thanwomen,with a 3:1 ratio.5
The disease is familial in about half the cases and typically
shows an autosomal dominant inheritance, with reduced
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Open access under CC BY-NC-ND license.encoding several components of the cardiac desmosome6e10
are associated with ARVC in about 50% of probands.3 The
presence of multiple mutations in desmosomal genes have
been reported in a signiﬁcant proportion of cases.11,12 Non-
desmosomal ARVC genes have also been identiﬁed,3
providing evidence that ARVC pathogenesis extends beyond
the desmosomes. Currently, only a novel mutation in the DES
gene encoding for desmin, the intermediate ﬁlament protein
expressed by cardiac cells, has been identiﬁed in a proband
showing a typical form of ARVC.13 We report the mutation
screening of the DES gene in a cohort of Italian patients with
ARVC to establish the prevalence of DES mutations.
Methods
We included 91 unrelated patients of Italian descent with
ARVC. The clinical evaluation consisted of a detailed
personal and family history, physical examination, 12-lead
electrocardiogram (ECG), 2-dimensional echocardiogram,
signal-averaged ECG, and stress test ECG, performed
according to previously reported methods.14 In all probands,
a clinical diagnosis of ARVC was made using the revised
2010 Task Force criteria.15 None of these patients showed
skeletal muscle disease. Available family members of the
probands carrying DES variants were also clinically evalu-
ated. All clinical investigations were conducted according to
the principles expressed in the Declaration of Helsinki.www.ajconline.org
Table 1
Nucleotide substitutions identiﬁed in Desmin gene in patients affected with arrhythmogenic right ventricular cardiomyopathy (ARVC)
Exon Nucleotide Change Amino Acid Change dbSNP/1000Genomes ID MAF
1 c.75A>G p.P25P rs1318299 0.089
1 c.93T>C p.S31S rs2017800 0.100
1 c.408C>T p.L136L rs111828114 0.021
Intron 1 c.579-38C>T  rs12991025 0.456
2 c.638C>T p.A213V rs41272699 0.008; 0.012*
3 c.669T>C p.I223I rs75882680 0.022
3 c.721A>G p.K241E 1000GENOMES_2_220285054 <0.01; 0.000*
Intron 3 c.735þ20C>T  rs151226355 0.005; 0.013*
Intron 3 c.736-35C>A  rs41272701 0.018
Intron 3 c.736-11A>G  novel (GenBank JX114779) 0.000*
4 c.828C>T p.D276D rs1058261 0.347
5 c.1014G>C p.L338L rs12920 0.347
6 c.1104G>A p.A368A rs1058284 0.342
ID ¼ identiﬁcation number; MAF ¼ minor allele frequency.
* MAF estimated in the Italian control population for nucleotide changes not reported in SNP databases or showing MAF <0.01.
Figure 1. DES variants identiﬁed in patients with ARVC. (Top) Sequence electropherograms showing p.A213V and p.K241E amino acid substitutions and
intronic nucleotide change c.736-11A>G detected in DES gene. (Bottom) ClustalW (European Molecular Biology LaboratoryeEuropean Bioinformatics
Institute, Cambridgeshire, United Kingdom) alignment showing evolutionary conservation of highly conserved 1B desmin subdomain among species.
Organism names and Genbank Accession numbers are reported on the sides (Cf ¼ Canis familiaris; Dr ¼ Danio rerio; Gg ¼ Gallus gallus; Hs ¼ Homo
sapiens; Mm ¼ Mus musculus; Rn ¼ Rattus norvegicus; Ss ¼ Sus scrofa; Xl ¼ Xenopus laevis).
Cardiomyopathy/Desmin Mutations are Infrequent in ARVC 401The ethics committee review board of the University of
Padua (Padua, Italy) approved the study protocol. All the
participants provided written informed consent before
inclusion in the study. Of the 91 patients, 53 were ARVC
index cases and were negative for mutations in the desmo-
somal genes, and 38 patients carried desmosomal gene
mutations (11 in the plakophilin-2 [PKP2] gene, 13 in the
desmoplakin [DSP] gene, 7 in the desmoglein-2 [DSG2]
gene, 2 in the desmocollin-2 [DSC2] gene, and 5 with
multiple mutations).
Genomic DNA was isolated from peripheral blood
lymphocytes using standard procedures. Primers for poly-
merase chain reaction ampliﬁcation of the DES gene weredesigned using PRIMER3 software (available at: http://
frodo.wi.mit.edu/; Supplemental Table 1). Polymerase
chain reaction products were analyzed using denaturing
high-performance liquid chromatography and/or direct
sequencing. Denaturing high-performance liquid chroma-
tography analysis was performed using the WAVE
Nucleic Acid Fragment Analysis System 3500HT equipped
with the DNASep HT cartridge (Transgenomic, Omaha,
Nebraska). Temperatures for sample analysis were selected
using WAVE Navigator software (Transgenomic; Supple-
mental Table 1). Polymerase chain reaction fragments
showing an aberrant, temperature-modulated denaturing
high-performance liquid chromatography heteroduplex
Figure 2. Pedigree of patient with ARVC carrying DES p.K241E rare
variant. Index patient indicated by arrow. Black, white, and gray symbols
represent clinically affected subjects, unaffected subjects, and subjects with
unknown disease status, respectively. Presence (asterisk) or absence () of
gene variations shown.
402 The American Journal of Cardiology (www.ajconline.org)proﬁle were sequenced using the BIG DYE dideoxy-
terminator chemistry (PerkinElmer, Waltham, Massachu-
setts) on an ABI 3730XL DNA sequencer (PE Applied
Biosystems, Foster City, California). Chromas, version 1.5,
software (Technelysium, South Brisbane, Australia) and
Lasergene package computer programs (DNASTAR, Mad-
ison, Wisconsin) were used to edit, assemble, and translate
the sequence. Numbering of the DES nucleotides starts at
ATG and refers to GenBank accession number NM_001927
for the cDNA; the translation sequence was compared to the
reference sequence NP_001918. A control group of 300
healthy and unrelated subjects (600 alleles) from the Italian
population was used to exclude that novel variants could be
common DNA polymorphisms. All the controls were
matched to the probands by ancestry. The ampliﬁcation
refractory mutation system was used to screen the control
population for the presence of nucleotide changes identiﬁed
in the DES gene (c.638C>T, c.721A>G, and
c.736-11A>G). The primer sequence, amplicon size, and
ampliﬁcation annealing temperatures are reported in
Supplemental Table 2. Mutation screening was performed
for all available family members of index cases in which
a DES variant was detected.
Results
A systematic mutation screening in the DES coding
regions was performed in 53 ARVC unrelated index cases
negative for mutations in the desmosomal genes. Because
the occurrence of multiple mutations in ARVC has been
reported,11,12 the DNA of another 38 consecutive and
unrelated patients with desmosomal gene mutations (11 in
the PKP2 gene, 13 in the DSP gene, 7 in the DSG2 gene, 2
in the DSC2 gene, and 5 carrying multiple mutations) was
investigated for DES mutations.
Mutation analysis resulted in the identiﬁcation of
several nucleotide substitutions (Table 1). A heterozygous
nucleotide change, c.721A>G, resulting in the p.K241E
substitution, was identiﬁed in 1 patient (Figure 1). It was
not detected in 600 control chromosomes, in single
nucleotide polymorphism database (dbSNP; available at:
http://www.ncbi.nlm.nih.gov/projects/SNP/), or in the
Exome Variant Server (available at: http://evs.gs.
washington.edu/EVS/). Very recently, it was reported in
the 1000 Genomes Project database (available at: http://
www.1000genomes.org) with a minor allele frequency
of <0.01 (1000GENOMES_2_220285054). This noncon-
servative amino acid substitution, which was considered
intolerant by Condel (available at: http://bg.upf.edu/condel/
analysis), SIFT (available at: http://sift.jcvi.org/) and Poly-
Phen-2 (available at: http://genetics.bwh.harvard.edu/pph2/)
analysis, involves a highly conserved residue in the 1B
a-helix subdomain (Figure 1). The index case carrying the
p.K241E variant had no family history of juvenile sudden
death, ARVC, or skeletal muscle disease. He was diagnosed
at 25 years old after a sustained ventricular tachycardia. The
basal ECG showed the presence of negative T waves in
leads V1 to V5 in the absence of complete right bundle
branch block (QRS 120 ms). The 2-dimensional echo-
cardiogram showed severe dilation of the right ventricle
(RV) with marked hypokinesia of the free wall, reduced RVejection fraction, and mild dilation of the left ventricle. He
was affected by a severe form of ARVC and received an
implantable cardioverter deﬁbrillator at 34 years old. He was
found to carry a pathogenic frame shift mutation
(p.T816RfsX10) in PKP2 gene. The patient’s sister,
carrying only the same DES variant, was fully asymptomatic
clinically and did not show any cardiac abnormality on the
echocardiogram, ECG, or magnetic resonance imaging scan
(Figure 2).
The known c.638C>T nucleotide substitution, resulting
in a p.A213V amino acid change, was identiﬁed in 1 patient
who was negative for mutations in the desmosomal ARVC
genes (Figure 1). This variant currently appears in single
nucleotide polymorphism database (rs41272699, minor
allele frequency 0.8%). In the present study, it was detected
in the healthy controls at an allele frequency of 1.2%. The
index patient carrying the p.A213V variant was diagnosed at
47 years old after a presyncopal episode. The basal ECG
showed the presence of negative T waves in leads V1 to V3
in the absence of complete right bundle branch block (QRS
120 ms). Echocardiography showed mild RV dilation with
kinetic abnormalities in the RV free wall. Magnetic reso-
nance imaging conﬁrmed the presence of mild dilation of
the right ventricle, together with kinetic alterations of the
RV free wall, and showed adipose tissue inﬁltration along
the RV free wall. No family history of juvenile sudden
death, ARVC, or skeletal muscle disease was reported. No
family members were available for clinical and genetic
testing.
A heterozygous nucleotide change close to the acceptor
splice site of exon 4 (c.736-11A>G) was identiﬁed in 1
patient in whom no mutation was detected in the desmo-
somal ARVC genes (Figure 1). He was examined at 46
years old because of effort dyspnea. The basal ECG showed
the presence of negative T waves in leads V1 to V3 in the
Table 2
Desmin mutations associated with arrhythmogenic right ventricular cardiomyopathy (ARVC)
Mutation Index Cases (n) Population Phenotype Investigators
c.38C>T, p.S13F 8 Dutch Desminopathy (ARVC in 2 relatives) van Tintelen et al20; van Spaendonck-Zwarts et al21
c.347A>G, p.N116S 1 of 22 German ARVC Klauke et al13
c.1024A>G, p.N342D 3 Dutch Desminopathy (plus ARVC in 1 relative) van Spaendonck-Zwarts et al21; Otten et al23
c.1255C>T, p.P419S 1 Swedish Myoﬁbrillar myopathy plus ARVC Hedberg et al24
Cardiomyopathy/Desmin Mutations are Infrequent in ARVC 403absence of complete right bundle branch block and an
epsilon wave in the right precordial leads. The 2-dimen-
sional echocardiogram revealed the presence of severe RV
dilation, depression of the RV fractional area change, apical
and subtricuspid akinesia, and apical sacculations. The
detected unclassiﬁed variant, which was absent in 600
control chromosomes and in the above-mentioned data-
bases, was identiﬁed in 2 of 5 affected and 3 unaffected
members of the family. No skeletal muscle and cardiac
biopsy samples were available to perform additional studies
to check for perturbed splicing of the DES mRNA transcript.
On the basis of the absence of co-segregation with the
disease phenotype and the identiﬁcation in unaffected
family members, this intronic variant was unlikely the
causal mutation in this family.
Discussion
Desmin is encoded by a single copy gene located on
chromosome 2q35. In the skeletal and cardiac muscle cells,
it forms a ﬂexible 3-dimensional scaffold around the
myoﬁbrillar Z-discs, connecting them to the plasma
membrane, nuclear lamina, mitochondria, and desmosomes
and aligning the myoﬁbrils.16 Therefore, desmin plays key
structural and signaling roles in myocytes and is critical for
cytoskeletal organization and maintaining the car-
diomyocyte structure.17
Currently, >50 different DES mutations have been iden-
tiﬁed worldwide. Mutations in the DES gene result in
formation of inclusion bodies, weakening of the desmin
cytoskeleton, disruption of subcellular organelle organiza-
tion, and, eventually, myoﬁbril degradation. These muscle
disorders are referred to as desmin-related myopathies or
desminopathies. They often present in young childhood, with
patients experiencing increasing muscle weakness, and are
associated with a wide spectrum of clinical phenotypes, even
within the same family. These range from scapuloperoneal,
limb girdle, and distal phenotypes with variable cardiac or
respiratory involvement to pure cardiomyopathies.18
To the best of our knowledge, only 1 DES mutation
(p.N116S) was identiﬁed in a German patient with ARVC.13
The amino acid substitution leads to aggresome formation in
cardiac and skeletal muscle without signs of an overt clinical
myopathy.13,19 However, the 17-year-old mutation carrier
showed concomitant subclinical skeletal muscle alterations.
All other reported ARVC-related DES mutations underlie
a clinically heterogeneous phenotype, frequently associated
with muscle alterations (Table 2). The p.S13F mutation was
identiﬁed in 39 family members from 8 Dutch families.20,21
This mutation was frequently associated with a myopathy
and with a wide spectrum of cardiomyopathies. ARVC wasfound in only 2 cases. The p.N342D mutation has been
described previously in patients affected with desmin-
related myopathies22; van Spaendonck-Zwarts et al21 and
Otten et al23 were the ﬁrst to demonstrate the association of
this mutation with RV cardiomyopathy. Among 21 carriers
of the p.N342D substitution from 3 different families
showing a variable neuromuscular phenotype with cardiac
involvement, ARVC was diagnosed in only 1. More
recently, the p.P419S mutation has been identiﬁed by exome
sequencing in a large Swedish family showing myoﬁbrillar
myopathy and ARVC, previously linked to chromosome
10q22.3 markers (ARVC7 locus, MIM 609160).24 No
additional DES mutations were found in a set of 50 Dutch
patients with an ARVC-like disorder23 and in a large series
of 143 unrelated North American probands diagnosed with
ARVC.12
In the present study, we focused on mutation screening of
the DES gene, a recent player in the growing ﬁeld of
ARVC-associated genes, in a large and well-studied cohort
of Italian patients with a typical form of ARVC. Two rare
missense variants, both with a possible modiﬁer effect, were
identiﬁed in 2 of 91 index cases (2.2%). These ﬁndings help
to establish that, in the absence of skeletal muscle
involvement suggestive of a desminopathy, the probability
of DES mutations in ARVC is very low. The p.K241E
substitution was found in 1 patient who carried a 2-base pair
deletion (c.2447_2448delCC) in exon 12 of PKP2 gene.
This frame shift mutation (p.T816RfsX10), identiﬁed in
another ARVC proband,12 is expected to cause an important
change in the protein structure, introducing a premature stop
codon in the ARM-domain 8 of PKP2. The p.K241E
substitution, recently reported in the 1000 Genomes Project
database with a very low minor allele frequency, involves
a highly conserved residue and is predicted to cause an
intolerant amino acid change. On the basis of these data, this
DES substitution can be considered a rare variant with
a possible modiﬁer effect on the phenotypic expression of
the concomitant PKP2 mutation. The previously known
DES p.A213V amino acid change was identiﬁed in 1 patient
with ARVC who was negative for mutations in the
desmosomal genes. In the published data, this substitution
has been associated with 3 completely different clinical
phenotypes: restrictive cardiomyopathy, dilated cardiomy-
opathy and isolated distal myopathy.25e27 However, the
identiﬁcation of this substitution in healthy controls has
raised the hypothesis that the p.A213V shift represents
a rare polymorphism rather than a true disease-causing
mutation. Recently, a high prevalence of p.A213V substi-
tution was reported in patients with heart dilation of
various origins.28 Although p.A213V desmin did not show
a clear in vitro functional effect in transfected HeLa cells,
404 The American Journal of Cardiology (www.ajconline.org)Kostareva et al28 speculated that its altered biophysical
properties can predispose to cardiac vulnerability in the
presence of unfavorable factors. Therefore, over-
representation of p.A213V in patients with cardiac dilation
supports the hypothesis that this rare variant might have an
unfavorable effect on cardiac remodelling under stressful
conditions. Likewise, the p.A213V substitution detected in
a patient with ARVC in the present study could play a pre-
disposing role in heart remodeling in the presence of an
additional, as yet unidentiﬁed, disease-causing mutation.
Future studies should be planned to screen for novel
genes other than desmosomal genes, especially in the Next
Generation Sequencing era, to better deﬁne the etiopatho-
genesis of ARVC. The maturation of the recently developed
Next Generation Sequencing technologies provides
unprecedented sequencing capacity at dramatically lower
cost and will be particularly useful for mutation screening in
patients affected with this highly genetic heterogeneous
disease. However, the use of Next Generation Sequencing to
identify gene mutations could face huge challenges, in
particular, in small families and sporadic cases, to discern
the disease-causing variants from those that by chance alone
are carried by the affected persons.Acknowledgment: We are grateful to all the family
members who kindly participated in the present study and to
Mrs. Paola Marcon for her invaluable help in collecting
family data.Supplementary data
Supplementary data related to this article can be found
online at http://dx.doi.org/10.1016/j.amjcard.2012.10.017Disclosures
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